FRANKFURT (Reuters) -Britain’s AstraZeneca has agreed to buy U.S. drugmaker Alexion (NASDAQ:ALXN) Pharmaceuticals for $39 billion in its largest ever deal, diversifying away from its fast-growing cancer business in a…
Trending News
April 13, 2025
February 26, 2025
February 23, 2025
February 23, 2025
February 17, 2025